Generalist Cohort of Migrant Patients Consultants in City Medicine (CoPAMViL)

State of Health and Integration Into the Health Care System of Migrant Patients, New Arrivals, Consultants in Urban Primary Care Structures,in Seine Saint Denis and in the North of Paris.

This innovative cross-sectional study, carried out in the city, will provide valuable prospective data that will make it possible to identify public health avenues for specific and adapted care both in the medical and social field of newcomers to our territory. Our study will characterize the impact of reforms of the conditions of access to State medical aid and universal health protection on access to care and the state of health of this population. . It will make it possible to participate in the advocacy in favor of access to healthcare for all and the city PASS, the only device allowing access to healthcare in the city for all newcomers regardless of their status.

Study Overview

Detailed Description

Participants will be informed orally and via an information note written by the doctor during their first medical contact in France or during a follow-up visit within the municipal health center.

The health data comes from the participant's care file and some social data is extracted from the social information system, already existing and used by the reception agents responsible for the consultations. access to rights.

Inclusion visit :

This visit will take place during the first medical visit of eligible patients.

During this visit, the investigative team:

  • Checks the inclusion and non-inclusion criteria;
  • Gives clear oral and written information;
  • Collect the patient's non-opposition;
  • Performs the medico-social consultation in accordance with the management recommendations.

Follow-up visits Follow-up will be continued 12 months after the inclusion visit. The rhythm, as well as the nature of the follow-up visits for the patients included, will be defined by the information obtained during the inclusion visit, and will be determined by the doctor in charge of the patient.

For patients included retrospectively The inclusion visit will take place during a follow-up medico-social visit planned as part of the care in one of the participating the municipal health center.

During this visit, the investigative team:

  • Checks the inclusion and non-inclusion criteria;
  • Gives clear oral and written information;
  • Collect the patient's non-opposition;
  • Performs the medico-social consultation in accordance with the management recommendations

During the inclusion visit and medical follow-up visits, within the Municipal Health Centers, a consultation on access to rights will also be carried out in order to help patients put together their social file.

Study Type

Observational

Enrollment (Actual)

197

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aubervilliers, France, 93000
        • CMS Aubervilliers
      • Saint-Denis, France, 93200
        • CMS Saint-Denis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

specific population of major newcomer migrants

Description

Inclusion Criteria:

  • Adults (age ≥ 18 years)
  • Newly arrived migrants (foreigners born outside France, first arrival in France AND presence in the territory ≤ 1 year)
  • 1st medical contact in town medicine in France

Exclusion Criteria:

  • Refusal of participation
  • Communication impossible due to the language barrier despite translation or interpreting (telephone or face-to-face)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of medical and social consultations one year after inclusion.
Time Frame: one year after arrival in France
describe the state of health of newly arrived migrant patients in the year following their arrival in France
one year after arrival in France
Number of newcomer biological assessments prescribed by the doctor one year after inclusion
Time Frame: one year after arrival in France
describe the state of health of newly arrived migrant patients in the year following their arrival in France
one year after arrival in France

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2021

Primary Completion (Actual)

November 25, 2022

Study Completion (Actual)

November 25, 2023

Study Registration Dates

First Submitted

July 19, 2021

First Submitted That Met QC Criteria

August 3, 2021

First Posted (Actual)

August 4, 2021

Study Record Updates

Last Update Posted (Actual)

July 1, 2024

Last Update Submitted That Met QC Criteria

June 28, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • APHP210936

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

  • The data will be entered in an electronic CRF: Cleanweb®, hosted in France on a health data host.
  • Allocation of an individual code to each participant eligible for the research: center number, serial number in the research, initial Last name and initial First name
  • Use of a correspondence table (kept in the center by the principal investigator until the publication of the research article)

Non-identifying data will be entered into an electronic Cleanweb CRF and each participant will be assigned an individual code.

The computer session and access to the e-CRF will be protected by a user code and a password.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Care System for Newly Arrived Migrants

Clinical Trials on the state of health of newly arrived migrant patients in the year following their arrival in France

Subscribe